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Abstracts / Osteoarthritis and Cartilage 21 (2013) S9–S62 S35Main outcome measures: The primary outcome was self-reported
physical function measured on the Activity of Daily Living (ADL)
subscale in the HOOS/KOOS questionnaires for hip and knee patients,
respectively. The primary end-point was 3 months after surgery. The
main secondary outcome was HOOS/KOOS Pain subscale.
Results: 165 patients randomised to the two groups were on average
67(SD8) years, 84 (51%) hadhipOAand92 (56%)werewomen.153 (93%)
underwent planned surgery and were evaluated postoperatively. There
was no statistically signiﬁcant difference in treatment effects between hip
or knee patients (p ¼ 0.7370). Three months postoperatively (primary
endpoint), no difference was found between groups for physical function
(4.4, 95% CI -0.8 to 9.5) or pain (4.5, 95% CI -0.8 to 9.9). However, therewas
a statistically signiﬁcant difference indicating an effect of exercise seen
over the entireperiod (baseline to3monthspostoperatively) (p¼0.0029).
Conclusion: Eight weeks of supervised neuromuscular exercise prior to
total joint arthroplasty (TJA) of the hip or knee did not confer additional
beneﬁts compared with TJA alone at 3 months after surgery. However,
the intervention group experienced a statistically signiﬁcant short-term
beneﬁt in physical function and pain, suggesting an earlier onset of
postoperative recovery.
Trial registration: ClinicalTrials NCT01003756.Large variability was seen in Harris Hip Scores and gait changes after total hip arthroplasty
Preoperative Mean(SD) Postoperative Mean (SD) Mean Change (SD) Change Range
Harris Hip Score 56.80 (13.94) 91.4 (10.9) 34.6 (16.1) -10 to +65
Speed (m/s) 1.02 (0.24) 1.19 (0.19) 0.17 (0.2) -0.36 to +0.82
Dynamic Hip Range of Motion (deg) 15.5 (6.0) 25.4 (6.2) 8.9 (5.8) -14.4 to +23.0
Peak Flexion Moment (%BWxHt) 4.29 (1.60) 5.95 (2.02) 1.66 (1.89) -5.08 to +7.01
Peak Extension Moment (%BWxHt) 1.78 (0.79) 2.74 (1.07) 0.96 (1.03) -1.40 to +5.08
Peak Adduction Moment (%BWxHt) 3.42 (1.07) 3.46 (0.96) 0.03 (1.15) -2.68 to +3.64
Peak Abduction Moment (%BWxHt) 1.64 (0.84) 1.91 (0.85) 0.27 (0.81) -1.82 to +2.35
Peak Internal Rotation Moment (%BWxHt) 0.37 (0.21) 0.50 (0.20) 0.12 (0.19) -0.35 to +0.63
Peak External Rotation Moment (%BWxHt) 0.33 (0.21) 0.42 (0.23) 0.09 (0.21) -0.41 to 0.68 -0.41 to 0.6854
AGE, GENDER, AND BODY MASS INDEX DO NOT EXPLAIN
INDIVIDUAL VARIABILITY IN CLINICAL AND GAIT RECOVERY AFTER
TOTAL HIP ARTHROPLASTY
O.A. Behery, K.C. Foucher. Rush Univ. Med. Ctr., Chicago, IL, USA
Purpose: After undergoing total hip arthroplasty (THA) for hip osteo-
arthritis, many patients have residual pain and functional deﬁcits and
persistent biomechanical deﬁcits measured using quantitative gait
analysis. Age, gender and body mass index (BMI) have been linked to
variability in clinical outcomes, with results differing by study. The
effect of these factors on the improvement in gait has never been
studied. The purpose of this study was to determine whether age,
gender, or BMI are related to change in clinical scores and gait variables
after THA.
Methods: We identiﬁed 125 subjects from an IRB-approved data
repository who were evaluated before and primary unilateral THA: age
61  10 y (range 27-85); 63 M /62 F; BMI 28.2  5.0 kg/m2 (range
18.5-47.4); follow-up time 159 mos (range 6-37). Gait analysis was
conducted using standard published methods. Variables analyzed
were speed, dynamic hip range of motion and 3D peak external
moments normalized to body weight and height (%BWxHt), averaged
from 2-4 trials collected at subjects’ self-selected normal walking
speed. The clinical outcome tool used was the Harris hip score (HHS),
which includes pain, function and activity domains and is scored from
0-100 (best). We used Pearson correlations to assess relationships
between age, BMI and gender and the change in HHS and gait vari-
ables. We also grouped subjects by age (<65, 65), gender (M / F), and
BMI (<25, 25-29.9, 30) and used t-tests and ANOVA to determine
whether pre-to-post change in HHS and gait variables differed
between groups.
Results: Substantial variation was seen in HHS and gait changes
(Table 1). On average, all variables signiﬁcantly increased (p<0.001)except for the peak adduction moment (p¼0.759). Individual change in
this moment, which reﬂects net hip abductor activity, ranged from
a decrease of 55% to an increase of 220% (Figure 1). There were no
signiﬁcant age or BMI correlations or group differences (p¼ 0.100-
0.972). Regarding gender, the hip adduction moment tended to increase
postoperatively in women (+0.231.3 %BWxHt) and decrease in men
(-0.161.0 %BWxHt) but this differences was not quite statistically
signiﬁcant (p¼ 0.055). Given the overlapping ranges of values, the lack
of differences in the other moments that reﬂect hip abductor function
(e.g. the internal and external rotation moments) and the number of
comparisons performed, this difference is not likely clinically mean-
ingful. No other gender comparisons approached signiﬁcance (p¼0.105-
0.988).
Conclusions: Considerable variability was present in both clinical and
gait changes after THA. The amount of variability in the pre-to-post
change in the peak adduction moment, which reﬂects hip abductor
function, was particularly noteworthy. Age, gender and BMI were not
related to HHS or gait changes. These ﬁndings suggest that THA can
provide signiﬁcant improvement for patients regardless of age, gender
or BMI, but more work is needed to identify factors related poor clinical
or biomechanical responses.Figure 1. Histograms showing the pre-to post-operative changes in peak adduction
moment and Harris Hip Score in our subject sample illustrate substantial individual
variation in improvement of clinical and gait outcomes after total hip arthroplasty.
Notably, the Harris Hip Score decreased for 4 (3%) subjects, while the peak adduction
moment declined for 61 (49%) subjects.
55
IN HUMAN CHONDROCYTES DNMT-1 PLAYS A KEY ROLE IN THE
EXPRESSION OF SEVERAL GENES ASSOCIATED WITH THE
PATHOGENESIS OF OSTEOARTHRITIS (OA)
N. Akhtar, T.M. Haqqi. NEOMED Univ., Dept. Anatomy & Neurobiology,
Rootstown, OH, USA
Introduction: Recent evidence points to chromatin remodeling as a key
event in the expression of several genes associated with OA patho-
genesis. IL-1b is the principal cytokine involved in cartilage catabolism
in OA. The aim of this study was to investigate (a) whether IL-1b
modulates DNA methylation content in human chondrocytes; and if so
(b) how the DNA methylation status affect the expression of selected
